Agentic AI in pharma marketing: what it is, and what it still needs a human for
The real difference between a single-prompt AI tool and an agentic one, and where human judgment still sits in the loop.
"Agentic" gets applied loosely enough that it's worth being specific about what it actually changes. In pharma marketing, the meaningful difference isn't that the AI is smarter. It's that the work is broken into distinct roles that hand off to each other, instead of one model doing everything in a single pass.
What it is
A single-prompt AI tool takes an instruction and produces an output in one step: you ask, it answers. An agentic system instead splits a task the way a real team would, into roles that each own a specific part of the job and pass their work to the next role in sequence. In SwishX's case, that's five specialist roles, a Project Manager, Content Strategist, Medical Writer, Creative Producer, and MLR Reviewer, each handling the part of the job a human specialist in that role would normally handle, carrying a brief from intake through to a review-ready asset.
The practical difference this makes: a claim doesn't just get written, it gets written by a role whose specific job is linking it to an approved source, and then checked again by a role whose job is verifying it against fair balance and label requirements, before the asset is considered done.
Why it matters
Splitting work into roles is what makes compliance checking a structural part of production instead of a separate pass applied afterward. A single-prompt system that's asked to "write compliant copy" is relying on the model to hold every constraint in mind at once, claims, tone, fair balance, ISI placement, while also trying to write well. An agentic system doesn't ask one step to do all of that. It assigns the claim-checking to a role built for exactly that, running alongside the writing rather than depending on the writer to remember it.
That structural separation is also what makes the process auditable. Because each role's output is a distinct, inspectable step, it's possible to see specifically where a claim was linked, or where a fair-balance check ran, rather than treating the whole thing as one opaque generation.
How it actually works
Even with roles split out, agentic doesn't mean unsupervised. A few things still sit with a human, by design:
- The brand dossier itself: the approved claims, regulatory ruleset, and brand voice that every role generates from are configured by the account's own team, not invented by the system. The agents work from what's given to them; they don't decide what's approved.
- Final MLR sign-off: an MLR-ready asset, one that entered review clean on claims, references, and fair balance, still goes through an organization's actual MLR process. Structural compliance checks reduce what reaches that review needing correction. They don't replace the review itself.
- Judgment calls a rule can't resolve: fair balance, for instance, is a judgment about comparable prominence and comprehension, not a fixed formula. A system can flag a proportion that looks off. Deciding whether it's actually sufficient is still a human call.